Edition:
United States

Teligent Inc (TLGT.OQ)

TLGT.OQ on NASDAQ Stock Exchange Global Select Market

2.56USD
16 Nov 2018
Change (% chg)

-- (--)
Prev Close
$2.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
69,954
52-wk High
$4.52
52-wk Low
$2.36

Latest Key Developments (Source: Significant Developments)

Teligent Q3 Revenue Rose 42 Percent To $18.3 Million
Tuesday, 13 Nov 2018 04:15pm EST 

Teligent Inc ::TELIGENT, INC. ANNOUNCES THIRD QUARTER 2018 RESULTS.Q3 REVENUE ROSE 42 PERCENT TO $18.3 MILLION.QTRLY NON-GAAP ADJUSTED NET LOSS PER DILUTED SHARE $0.00.  Full Article

Teligent, Inc. Announces $120 Million Financing Commitment From Ares
Tuesday, 13 Nov 2018 04:15pm EST 

Teligent Inc ::TELIGENT, INC. ANNOUNCES $120 MILLION FINANCING COMMITMENT FROM ARES.TELIGENT INC - SECURED A FINANCING COMMITMENT FROM FUNDS MANAGED BY ARES MANAGEMENT LP ON NOVEMBER 12, 2018.TELIGENT INC - $80 MILLION OF TERM LOANS WILL BE USED TO REDEEM COMPANY'S DECEMBER 2019 CONVERTIBLE BONDS, AS WELL AS PROVIDE FURTHER LIQUIDITY.  Full Article

FDA Grants Teligent Approval Of Ciclopirox Shampoo, 1%
Friday, 6 Apr 2018 10:32am EDT 

April 6 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF CICLOPIROX SHAMPOO, 1%.‍RECEIVED APPROVAL OF CO'S ABBREVIATED NEW DRUG APPLICATION FROM U.S. FDA OF CICLOPIROX SHAMPOO, 1%​.  Full Article

Teligent, Inc. Announces FDA Approval Of Halobetasol Propionate Ointment, 0.05%
Wednesday, 21 Mar 2018 08:30am EDT 

March 21 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF HALOBETASOL PROPIONATE OINTMENT, 0.05%.TELIGENT INC - EXPECT TO LAUNCH HALOBETASOL PROPIONATE OINTMENT, 0.05% IN Q2 OF 2018.  Full Article

Teligent, Inc. Announces Qtrly Loss Per Share $0.11​
Thursday, 15 Mar 2018 04:12pm EDT 

March 15 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2017 RESULTS.Q4 REVENUE FELL 10 PERCENT TO $16.1 MILLION.SEES FY 2018 REVENUE $70 MILLION TO $78 MILLION.QTRLY LOSS PER SHARE $0.11​.  Full Article

Teligent Inc Announces FDA Approval Of Betamethasone Dipropionate Lotion USP 0.05 Pct
Wednesday, 14 Feb 2018 09:31am EST 

Feb 14 (Reuters) - Teligent Inc ::TELIGENT INC ANNOUNCES FDA APPROVAL OF BETAMETHASONE DIPROPIONATE LOTION USP (AUGMENTED), 0.05%.TELIGENT INC - ‍EXPECT TO LAUNCH BETAMETHASONE DIPROPIONATE LOTION USP IN Q1 OF 2018 ​.  Full Article

TELIGENT ANNOUNCES FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%
Wednesday, 22 Nov 2017 08:30am EST 

Nov 22 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%.TELIGENT, INC. ANNOUNCES FIRST FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%.TELIGENT INC- ‍EXPECT TO LAUNCH HYDROCORTISONE BUTYRATE LOTION 0.1%​ IN Q1 OF 2018.  Full Article

TELIGENT ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%
Tuesday, 21 Nov 2017 08:30am EST 

Nov 21 (Reuters) - Teligent Inc ::TELIGENT, INC. ANNOUNCES FDA APPROVAL OF ERYTHROMYCIN TOPICAL SOLUTION USP, 2%.TELIGENT INC- ‍EXPECT TO LAUNCH ERYTHROMYCIN TOPICAL SOLUTION USP, 2% BEFORE THE END 2017.  Full Article

Teligent announces FDA approval of betamethasone dipropionate ointment usp (augmented), 0.05%​
Friday, 10 Nov 2017 09:20am EST 

Nov 10 (Reuters) - Teligent Inc ::Announces FDA approval of betamethasone dipropionate ointment USP (augmented), 0.05%​.Expect to launch betamethasone dipropionate ointment USP (augmented), 0.05% in Q1 of 2018​.  Full Article

Teligent posts Q3 qtrly ‍loss per share $0.12​
Monday, 6 Nov 2017 04:05pm EST 

Nov 6 (Reuters) - Teligent Inc :Teligent Inc announces third quarter 2017 results.Sees FY 2017 revenue $65 million to $67 million.Q3 revenue fell 15 percent to $13.7 million.Teligent Inc qtrly ‍loss per share $0.12​.Q3 earnings per share view $-0.01, revenue view $19.1 million -- Thomson Reuters I/B/E/S.Teligent Inc - ‍now anticipates gross margin of 38% to 40% for year ending december 31, 2017​.Teligent - Q3 ‍results, revised FY outlook due to knock-on effect of ANDA approval delays, increased competition in one of our largest products​.  Full Article